MediPharm Labs Settles an Outstanding Claim for $9M
TORONTO, Oct. 2, 2023 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a company specialized in precision-based cannabinoids,…